Latest Regulatory Uncertainty News

Island Pharmaceuticals reports a 213.8% increase in half-year loss to $4.81 million, driven by strategic acquisition and clinical development investments. The company advances its antiviral portfolio with Galidesivir and ISLA-101, supported by strong US regulatory engagement and a $9 million capital raise.

Woodside Energy Group Ltd reported record production and a net profit after tax of $2.7 billion in 2025, advancing key LNG and ammonia projects while achieving its 15% emissions reduction target.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

Marimaca Copper has successfully raised C$409 million through a dual Canadian and Australian equity offering, positioning the company to advance its flagship Marimaca Project and exploration at Pampa Medina.

MEC Resources Ltd reported a half-year loss of $431,971 amid ongoing legal challenges over key gas exploration permits, while progressing investments in clean energy and neurotechnology. The company also completed a $359K options placement, reinforcing its financial position.

St George Mining has reported exceptional drilling results at its Araxá Rare Earths and Niobium Project in Brazil, including a record 164.45m mineralised intercept from surface. These results expand the known resource footprint well beyond current estimates, signalling significant growth potential.

Black Bear Minerals has confirmed all major permits for its Shafter Silver Project in Texas, clearing a critical hurdle for a near-term restart amid strong silver market dynamics and U.S. strategic support.

Contact Energy has announced a $525 million equity raise to accelerate its renewable energy projects, following a strong first half of FY26 with significant profit growth and strategic acquisitions.

Manuka Resources has affirmed the material significance of a draft decision by New Zealand’s EPA declining consent for its Taranaki VTM Project, clarifying its disclosure timeline and compliance with ASX rules amid recent share price volatility.

Oneview Healthcare reported a robust 21% increase in revenue for FY2025, driven by recurring revenue growth and new customer acquisitions. The company is advancing AI-powered solutions and targeting operational breakeven in 2026.

Evolution Energy Minerals Limited has announced a renounceable pro-rata entitlement offer to raise up to $4.03 million, aiming to fund exploration and development of its Tanzanian copper and graphite assets. The offer includes free attaching options and is partially underwritten, reflecting both opportunity and risk amid regulatory challenges.

Altamin Limited has obtained a retrospective Environmental Impact Assessment approval for its Gorno Project in Italy, strengthening its regulatory footing and supporting strategic options for development.